Medical knowledge · Legal judgment · Human agency

GLP-1 Drug Lawsuit

Mounjaro Lawsuit

Serious Health Risks from Tirzepatide Injections

Mounjaro (tirzepatide) has been linked to thyroid cancer, pancreatitis, and severe gastrointestinal injuries. If you've been harmed by Mounjaro, you may have a legal claim.

What Is Mounjaro?

Mounjaro (tirzepatide) is a GLP-1 receptor agonist approved by the FDA for treating type 2 diabetes. It has become popular off-label for weight loss, similar to Ozempic and Wegovy.

Manufactured by Eli Lilly, Mounjaro works by increasing insulin secretion and decreasing appetite.

Health Risks and Alleged Injuries

Lawsuits allege that Mounjaro is linked to serious health conditions including thyroid cancer, pancreatitis, gastroparesis, and severe dehydration. Some users report lasting gastrointestinal issues after stopping the medication.

Plaintiffs claim that Eli Lilly failed to adequately warn patients and doctors about these serious risks.

Litigation Status

Multiple Mounjaro lawsuits have been filed in federal court and state courts across the United States. The litigation is in early stages, with discovery ongoing and settlement discussions beginning.

Thousands of individuals have reportedly suffered injuries they attribute to Mounjaro use.

Who May Qualify

Individuals who took Mounjaro and subsequently developed thyroid cancer, pancreatitis, severe gastroparesis, or other serious conditions may qualify for a claim. Medical records documenting the condition and linking it to Mounjaro use are essential.

You must have used the medication and developed health complications during or after treatment.

Next Steps

If you or a loved one took Mounjaro and developed serious health problems, contact our firm for a free case review. We will evaluate your claim, review medical records, and explain your legal options.

Time is limited to file claims, so prompt action is essential.

Free Case Review

Learn if you have a claim for Mounjaro-related injuries.

Start Your Review

No fees. No commitments. Confidential.

Key Facts

  • GLP-1 receptor agonist for diabetes and weight loss
  • Manufactured by Eli Lilly
  • Linked to thyroid cancer and pancreatitis
  • Nationwide litigation ongoing

The information on this page is for general informational purposes only and does not constitute legal advice.